Kronos Bio (KRON) Short Interest Ratio & Short Volume → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free KRON Stock Alerts $0.98 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Kronos Bio Short Interest DataCurrent Short Volume686,800 sharesPrevious Short Volume662,700 sharesChange Vs. Previous Month+3.64%Dollar Volume Sold Short$707,404.00Short Interest Ratio / Days to Cover1.7Last Record DateApril 30, 2024Outstanding Shares60,094,000 sharesFloat Size40,070,000 sharesShort Percent of Float1.71%Today's Trading Volume162,722 sharesAverage Trading Volume321,083 sharesToday's Volume Vs. Average51% Short Selling Kronos Bio ? Sign up to receive the latest short interest report for Kronos Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKRON Short Interest Over TimeKRON Days to Cover Over TimeKRON Percentage of Float Shorted Over Time Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. Kronos Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024686,800 shares $707,404.00 +3.6%1.7%1.7 $1.03 4/15/2024662,700 shares $755,478.00 -0.4%1.7%1.9 $1.14 3/31/2024665,000 shares $864,500.00 -0.4%1.7%2.6 $1.30 3/15/2024667,800 shares $774,648.00 +11.2%1.7%2.7 $1.16 2/29/2024600,400 shares $624,416.00 -1.8%1.6%2.3 $1.04 2/15/2024611,600 shares $660,528.00 +2.3%1.6%4.1 $1.08 Get the Latest News and Ratings for KRON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kronos Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024597,700 shares $675,401.00 -74.9%1.6%2.9 $1.13 1/15/20242,380,000 shares $2.81 million -0.4%6.3%10.9 $1.18 12/31/20232,390,000 shares $2.99 million -1.7%6.3%8.8 $1.25 12/15/20232,430,000 shares $3.62 million -10.7%6.4%8.8 $1.49 11/30/20232,720,000 shares $3.24 million -0.4%7.2%10.5 $1.19 11/15/20232,730,000 shares $2.48 million +0.4%7.3%10.6 $0.91 10/31/20232,720,000 shares $2.38 million -1.8%7.0%14 $0.87 10/15/20232,770,000 shares $2.75 million -0.7%7.2%15 $0.99 9/30/20232,790,000 shares $3.63 million -2.1%7.2%18.4 $1.30 9/15/20232,850,000 shares $3.51 million +0.7%7.4%10.7 $1.23 8/31/20232,830,000 shares $3.93 million No Change7.4%10 $1.39 8/15/20232,830,000 shares $4.67 million -1.4%7.4%9.4 $1.65 7/31/20232,870,000 shares $5.51 million -0.7%7.6%9.1 $1.92 7/15/20232,890,000 shares $6.01 million -13.2%7.6%7.1 $2.08 6/30/20233,330,000 shares $5.73 million -21.5%8.7%7.9 $1.72 6/15/20234,240,000 shares $7.21 million +5.2%11.0%10.5 $1.70 5/31/20234,030,000 shares $6.73 million +0.8%10.5%12.7 $1.67 5/15/20234,000,000 shares $7.48 million -5.0%10.4%12.6 $1.87 4/30/20234,210,000 shares $6.95 million -1.9%11.0%13.1 $1.65 4/15/20234,290,000 shares $5.58 million +3.6%11.2%14 $1.30 3/31/20234,140,000 shares $6.04 million +10.4%10.9%13.9 $1.46 3/15/20233,750,000 shares $5.63 million +7.5%9.9%12.3 $1.50 2/28/20233,490,000 shares $6.07 million +0.6%9.3%11.5 $1.74 2/15/20233,470,000 shares $7.25 million +1.2%9.3%11.6 $2.09 1/31/20233,430,000 shares $8.23 million -3.7%9.0%12 $2.40 1/15/20233,560,000 shares $9.33 million -0.3%9.4%13.6 $2.62 12/30/20223,570,000 shares $5.78 million -0.8%9.4%15.5 $1.62 12/15/20223,600,000 shares $6.66 million +1.7%9.5%18.7 $1.85 11/30/20223,540,000 shares $6.73 million -2.2%9.3%20.9 $1.90 11/15/20223,620,000 shares $8.65 million -1.4%9.5%20.3 $2.39 10/31/20223,670,000 shares $10.86 million No Change9.3%19.8 $2.96 10/15/20223,670,000 shares $10.42 million -0.3%9.3%17.1 $2.84 9/30/20223,680,000 shares $12.33 million +0.6%9.4%16.2 $3.35 9/15/20223,660,000 shares $17.53 million +3.7%9.3%14.1 $4.79Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. KRON Short Interest - Frequently Asked Questions What is Kronos Bio's current short interest? Short interest is the volume of Kronos Bio shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 686,800 shares of KRON short. 1.71% of Kronos Bio's shares are currently sold short. Learn More on Kronos Bio's current short interest. What is a good short interest ratio for Kronos Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRON shares currently have a short interest ratio of 2.0. Learn More on Kronos Bio's short interest ratio. What is a good short interest percentage for Kronos Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.71% of Kronos Bio's floating shares are currently sold short. Is Kronos Bio's short interest increasing or decreasing? Kronos Bio saw a increase in short interest in April. As of April 30th, there was short interest totaling 686,800 shares, an increase of 3.6% from the previous total of 662,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kronos Bio's float size? Kronos Bio currently has issued a total of 60,094,000 shares. Some of Kronos Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kronos Bio currently has a public float of 40,070,000 shares. How does Kronos Bio's short interest compare to its competitors? 1.71% of Kronos Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kronos Bio: CalciMedica, Inc. (0.93%), Carisma Therapeutics, Inc. (9.41%), Eagle Pharmaceuticals, Inc. (10.50%), Anebulo Pharmaceuticals, Inc. (0.19%), Immix Biopharma, Inc. (2.80%), Eledon Pharmaceuticals, Inc. (0.14%), Tiziana Life Sciences Ltd (0.38%), Kezar Life Sciences, Inc. (5.70%), Mural Oncology plc (11.13%), Checkpoint Therapeutics, Inc. (11.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Kronos Bio stock? Short selling KRON is an investing strategy that aims to generate trading profit from Kronos Bio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kronos Bio? A short squeeze for Kronos Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRON, which in turn drives the price of the stock up even further. How often is Kronos Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRON, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CalciMedica Short Interest Data Carisma Therapeutics Short Interest Data Eagle Pharmaceuticals Short Interest Data Anebulo Pharmaceuticals Short Interest Data Immix Biopharma Short Interest Data Eledon Pharmaceuticals Short Interest Data Tiziana Life Sciences Short Interest Data Kezar Life Sciences Short Interest Data Mural Oncology Short Interest Data Checkpoint Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRON) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & CompanyWhy Is Gold On a MASSIVE rally? Huge AlertsProtect Your Bank Account Before It’s Too LateWeiss Ratings